Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
COLUMN GROUP II, LP Insider Profile
25 Followers
COLUMN GROUP II, LP, Ten Percent Owner at Immune Design, holds 1.47M shares in RAPT Therapeutics (Ticker: RAPT), holds 3.57M shares in Oric Pharmaceuticals (Ticker: ORIC), holds 3.10M shares in Gritstone bio (Ticker: GRTSQ).
COLUMN GROUP II, LP Immune Design (IMDZ)Ten Percent Owner
Immune Design (IMDZ)
Ten Percent Owner
Ranked #1,533 out of 100,270 Corporate Insiders
Profitable Transactions
11 out of 13 Profitable Transactions
Average Return
+46.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that COLUMN GROUP II, LP holds in companies
Most Profitable Insider Trade
The most profitable trade made by COLUMN GROUP II, LP
COLUMN GROUP II, LP's Trading History
Immune Design
Sep 22, 2016
―
Informative Buy
―
$4.68M
Gritstone bio
Oct 02, 2018
Ten Percent Owner
Uninformative Buy
―
$34.13K
RAPT Therapeutics
Dec 23, 2024
Former 10% Owner
Uninformative Sell
―
$2.36M
Oric Pharmaceuticals
Nov 16, 2021
Ten Percent Owner
Uninformative Buy
266.00K
$32.90M
List of latest transactions for each holding click on a transaction to see COLUMN GROUP II, LP's performance on stock
You May Also Like
COLUMN GROUP II, LP insider profile FAQ
What is the percentage of profitable transactions made by COLUMN GROUP II, LP?
The percentage of profitable transactions made by COLUMN GROUP II, LP is 85%.
What is the average return per transaction made by COLUMN GROUP II, LP?
The average return per transaction made by COLUMN GROUP II, LP is 46.80%.
What stocks does COLUMN GROUP II, LP hold?
COLUMN GROUP II, LP holds: IMDZ, GRTSQ, RAPT, ORIC stocks.
What was COLUMN GROUP II, LP’s latest transaction?
COLUMN GROUP II, LP latest transaction was an Uninformative Sell of ―.
What was COLUMN GROUP II, LP's most profitable transaction?
COLUMN GROUP II, LP’s most profitable transaction was an Informative Buy of RAPT stock on November 4, 2019. The return on the trade was 110.60%.
What is COLUMN GROUP II, LP's role in Immune Design?
COLUMN GROUP II, LP's role in Immune Design is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.